Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label single-arm study of HEC53856 tablets for chemotherapy-induced anemia in patients with non-myeloid malignancies
CTR20231985Phase 2Completed
- Sponsor
- HEC Pharm
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HEC53856 in chemotherapy-induced anaemia (CIA), sponsored by HEC Pharm. Started Dec 2023; status: completed.
02
Drugs
HEC53856
03
Conditions
chemotherapy-induced anaemia (CIA)
Beyond the preview
Go deeper on CTR20231985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231985.